CRISPR-Cas9 Knockout: Design, Delivery, and Genotyping

sgRNA design · Cas9 delivery · Indel detection · Single-clone isolation · Validation

Published 2026 · Last updated 2026-09-27 · Hailu Zhou

Making a CRISPR knockout is now routine; making one you can defend is not. The nuclease is easy to deliver and cuts wherever a guide directs it, which means the experiment quickly reduces to three questions: did you cut the gene you intended, did the edit produce the allele you claim, and is the phenotype caused by the edit rather than by an off-target event or a clonal artefact. The design decisions and the validation strategy are what separate a useful knockout line from a story.

sgRNA design principles

The guide must be specific, efficient, and positioned to disrupt function. A few rules cover most cases:

Doench's Rule Set 2 and similar models predict on-target activity and are a reasonable starting filter, but the practical rule is to test two to four independent guides per gene and proceed with the ones that actually cut in your cells. Prediction accuracies are modest, and a guide that scores well in silico can fail at the bench.

Delivery: plasmid, mRNA, or RNP

How the components enter the cell determines the kinetics, the toxicity, and the persistence of editing.

For hard-to-transfect cells, viral delivery (lentivirus, AAV) is an option, with the caveat that AAV has a small cargo limit and that lentiviral integration adds its own randomness. For most knockout projects, start with RNP; fall back to plasmid for cell lines where electroporation is impractical.

Detecting indels: T7E1, Surveyor, and NGS

Cas9 cleavage is repaired by non-homologous end joining (NHEJ), which creates small insertions or deletions (indels) at the cut site. Detection methods vary in resolution and sensitivity.

Whatever the readout, the primers must amplify the region and the assay must include a wild-type control and an unedited control. A common mistake is to declare a clone edited solely on the basis of a band shift, without confirming the sequence and the resulting protein.

Single-clone isolation and what cloning hides

A pool of edited cells is a mosaic, so functional experiments usually require clonal lines. Limiting dilution or single-cell sorting into 96-well plates isolates clones, which are then expanded and genotyped. Cloning introduces its own problems.

Validating a knockout: the protein is the point

Genotype is a means; the question is whether the protein is gone. The validation ladder, in increasing strength:

The rescue experiment deserves emphasis. Re-expressing the wild-type protein in the knockout background and restoring the phenotype demonstrates that the edit, and not a second-site mutation or clonal adaptation, caused the effect. Where the protein is essential, an inducible rescue or a hypomorphic allele may be the only viable approach. Reporting the guide sequences, the delivery format, the exact alleles, the clone identity, and the validation evidence is what makes a knockout publishable and reusable.

References

  1. Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–821.
  2. Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–823.
  3. Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339(6121):823–826.
  4. Jinek M, East A, Cheng A, et al. RNA-programmed genome editing in human cells. eLife. 2013;2:e00471.
  5. Ran FA, Hsu PD, Wright J, et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281–2308.
  6. Doench JG, Fusi N, Sullender M, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34(2):184–191.
  7. Kim S, Kim D, Cho SW, et al. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 2014;24(6):1012–1019.
  8. Lin S, Staahl BT, Alla RK, Doudna JA. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. eLife. 2014;3:e04766.
  9. Vouillot L, Thélie A, Pollet N. Comparison of T7E1 and surveyor mismatch cleavage assays to detect mutations triggered by engineered nucleases. G3 (Bethesda). 2015;5(3):407–415.
  10. Brinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42(22):e168.